Biosimilars- What Clinicians Should Know
Advertorial: Biosimilars: What are they? How are they tested? Why do we need them?
Biologics are not generic medications. Generic drugs are small, chemically synthesized molecules identical to the corresponding branded product. Biosimilars are purified from products made in living cells.
Advertorial: Biosimilars, Evaluation, Efficacy, Safety, and Psychology
This communication briefly reviews the path to approval for biosimilars, studies that have provided additional information about the efficacy and safety of these products, and factors that may create barriers to their use, even after meeting all criteria for approval.
Advertorial: Biosimilars? What difference are they making?
It is well established that use of biosimilars decreases drug acquisition costs. The results summarized in this brief review show further that this savings can be translated into increased access to highly effective biologic medications and the savings appropriated to improve overall patient care. They also indicate that early use of biosimilars is cost-effective vs delaying an originator biologic until a course of conventional therapy has been delivered.
Newsletter
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Back to the cornea – Treating hyperopic patients with Lenticule Extraction
December 6th 2024Lenticule Extraction for treating patients with hyperopia is now available with SMILE® pro, performed on the VISUMAX® 800 from ZEISS. This additional option provides a valuable corneal-based alternative for younger patients without cataract. In this Case of the Month, you will discover the advantages of this procedure and review the outcomes of a 30-year-old patient who chose to undergo Lenticule Extraction with ZEISS SMILE pro after experiencing discomfort with contact lenses for many years.
My first experiences with AT ELANA 841P and ARTEVO 850
November 5th 2024This article by Liem Trinh, MD highlights his experiences with the AT ELANA® 841P hydrophobic trifocal IOL and the ARTEVO® 750 and ARTEVO® 850 microscopes from ZEISS. Dr. Trinh discusses the benefits of the trifocal design of the AT ELANA 841P IOL and its ability to provide spectacle independence at all distances after cataract surgery. He also shares his positive experiences with the ARTEVO 850 microscope, which offers improved surgical visualization with RGB LED illumination and 3D viewing on a high dynamic range monitor. Additionally, Dr. Trinh discusses the potential benefits of integrated intraoperative optical coherence tomography (OCT) and the redesigned CALLISTO eye user interface.
